Lipoprotein(a): More Than Just a Biomarker of Myocardial Fibrosis
- PMID: 38057071
- DOI: 10.1016/j.jacc.2023.10.019
Lipoprotein(a): More Than Just a Biomarker of Myocardial Fibrosis
Keywords: cardiac fibrosis; heart failure; lipoprotein(a); magnetic resonance.
Conflict of interest statement
Funding Support and Author Disclosures Dr Chemello is supported by the Agence Nationale de la Recherche (Paris, France) Project Grant KRINGLE2 ANR-20-CE14-0009. Prof Lambert has received consulting fees from Nyrada and Amgen. Dr Gallo has received consultancy fees and honoraria from Akcea Therapeutics, Amarin, Amgen, Eli Lilly, Mylan, Novartis, Sanofi, Servier, Ultragenyx, Unilever, Viatris, and Merck Sharp & Dohme. Dr Chemello has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Association of Lipoprotein(a) Levels With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis.J Am Coll Cardiol. 2023 Dec 12;82(24):2280-2291. doi: 10.1016/j.jacc.2023.10.016. J Am Coll Cardiol. 2023. PMID: 38057070 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
